Cargando…

Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat

AIM: To evaluate the hepatoprotective effect of lycopene (Ly) on non-alcoholic fatty liver disease (NAFLD) in rat. METHODS: A rat model of NAFLD was first established by feeding a high-fat diet for 14 wk. Sixty-five rats were randomly divided into normal group, model group and Ly treatment groups. A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Wei, Guo, Mei-Hua, Hai, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2016
Materias:	Basic Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155177/ https://www.ncbi.nlm.nih.gov/pubmed/28028366 http://dx.doi.org/10.3748/wjg.v22.i46.10180

Ejemplares similares

Antioxidant activity and hepatoprotective effect of 10 medicinal herbs on CCl(4)-induced liver injury in mice
por: Meng, Xiao, et al.
Publicado: (2020)

Green tea polyphenols ameliorate non-alcoholic fatty liver disease through upregulating AMPK activation in high fat fed Zucker fatty rats
por: Tan, Yi, et al.
Publicado: (2017)

Hepatoprotective effects of Hovenia dulcis seeds against alcoholic liver injury and related mechanisms investigated via network pharmacology
por: Meng, Xiao, et al.
Publicado: (2020)

Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease
por: Yang, Jia-Min, et al.
Publicado: (2019)

Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity/nonalcoholic fatty liver disease model in mice
por: Rodriguez-Echevarria, Roberto, et al.
Publicado: (2018)

miR-192-5p regulates lipid synthesis in non-alcoholic fatty liver disease through SCD-1
por: Liu, Xiao-Lin, et al.
Publicado: (2017)

In vitro and in vivo antioxidative and hepatoprotective activity of aqueous extract of Cortex Dictamni
por: Li, Lin, et al.
Publicado: (2017)

Procyanidin B2 protects against diet-induced obesity and non-alcoholic fatty liver disease via the modulation of the gut microbiota in rabbits
por: Xing, Ya-Wei, et al.
Publicado: (2019)

Papaya improves non-alcoholic fatty liver disease in obese rats by attenuating oxidative stress, inflammation and lipogenic gene expression
por: Deenin, Wanwisa, et al.
Publicado: (2021)

Freeze-dried Si-Ni-San powder can ameliorate high fat diet-induced non-alcoholic fatty liver disease
por: Zhu, Feng, et al.
Publicado: (2019)

Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease
por: Kostrzewski, Tomasz, et al.
Publicado: (2017)

Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease
por: Leung, Christopher, et al.
Publicado: (2016)

Lycopene Modulates Pathophysiological Processes of Non-Alcoholic Fatty Liver Disease in Obese Rats
por: Róvero Costa, Mariane, et al.
Publicado: (2019)

Partially hydrolyzed guar gum attenuates non-alcoholic fatty liver disease in mice through the gut-liver axis
por: Takayama, Shun, et al.
Publicado: (2021)

Fractionation of gamma-glutamyltransferase in patients with nonalcoholic fatty liver disease and alcoholic liver disease
por: Sueyoshi, Shigeo, et al.
Publicado: (2016)

Mechanism and therapeutic strategy of hepatic TM6SF2-deficient non-alcoholic fatty liver diseases via in vivo and in vitro experiments
por: Li, Zu-Yin, et al.
Publicado: (2022)

Zinc-α2-glycoprotein 1 attenuates non-alcoholic fatty liver disease by negatively regulating tumour necrosis factor-α
por: Liu, Ting, et al.
Publicado: (2019)

Preserved liver regeneration capacity after partial hepatectomy in rats with non-alcoholic steatohepatitis
por: Haldrup, David, et al.
Publicado: (2018)

Lycopene: Hepatoprotective and Antioxidant Effects toward Bisphenol A-Induced Toxicity in Female Wistar Rats
por: Abdel-Rahman, Haidy G., et al.
Publicado: (2018)

Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease
por: Saeed, Waqar Khalid, et al.
Publicado: (2018)

Prolonged high-fat-diet feeding promotes non-alcoholic fatty liver disease and alters gut microbiota in mice
por: Velázquez, Kandy T, et al.
Publicado: (2019)

Genetic polymorphism in CD14 gene, a co-receptor of TLR4 associated with non-alcoholic fatty liver disease
por: Kapil, Shweta, et al.
Publicado: (2016)

Lycopene modulates cellular proliferation, glycolysis and hepatic ultrastructure during hepatocellular carcinoma
por: Gupta, Prachi, et al.
Publicado: (2016)

Mediterranean Diet: The Beneficial Effects of Lycopene in Non-Alcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2022)

Hepatoprotective effects of Cassia semen ethanol extract on non-alcoholic fatty liver disease in experimental rat
por: Meng, Yuanyuan, et al.
Publicado: (2019)

Effects of ω-3 fatty acids on toll-like receptor 4 and nuclear factor-κB p56 in lungs of rats with severe acute pancreatitis
por: Wang, Bin, et al.
Publicado: (2016)

Antioxidant axis Nrf2-keap1-ARE in inhibition of alcoholic liver fibrosis by IL-22
por: Ni, Ya-Hui, et al.
Publicado: (2017)

F-box only protein 2 exacerbates non-alcoholic fatty liver disease by targeting the hydroxyl CoA dehydrogenase alpha subunit
por: Liu, Zhi, et al.
Publicado: (2023)

Hepatoprotective activity of aqueous extract of Portulaca oleracea in combination with lycopene in rats
por: Anusha, M., et al.
Publicado: (2011)

Antioxidant effects of aqueous extract of Salep on Paraquat-induced rat liver injury
por: Atashpour, Shekoufeh, et al.
Publicado: (2017)

Regulation of PPAR-γ activity in lipid-laden hepatocytes affects macrophage polarization and inflammation in nonalcoholic fatty liver disease
por: Li, Xiao-Yun, et al.
Publicado: (2022)

Anti-inflammatory and anti-oxidant effects of aloe vera in rats with non-alcoholic steatohepatitis
por: Klaikeaw, Naruemon, et al.
Publicado: (2020)

Hypothermic machine perfusion with metformin-University of Wisconsin solution for ex vivo preservation of standard and marginal liver grafts in a rat model
por: Chai, Yi-Chao, et al.
Publicado: (2017)

Effects of positive acceleration (+Gz stress) on liver enzymes, energy metabolism, and liver histology in rats
por: Shi, Bin, et al.
Publicado: (2019)

Hepatoprotective Effects of MHY3200 on High-Fat, Diet-Induced, Non-Alcoholic Fatty Liver Disease in Rats
por: Kim, Min Jo, et al.
Publicado: (2018)

Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease
por: Paka, Latha, et al.
Publicado: (2017)

Tomato lycopene prevention of alcoholic fatty liver disease and hepatocellular carcinoma development
por: Stice, Camilla P., et al.
Publicado: (2018)

In vivo recognition of bioactive substances of Polygonum multiflorum for protecting mitochondria against metabolic dysfunction-associated fatty liver disease
por: Yu, Li-Ping, et al.
Publicado: (2023)

Untargeted metabolomics characteristics of nonobese nonalcoholic fatty liver disease induced by high-temperature-processed feed in Sprague-Dawley rats
por: Xue, Li-Jun, et al.
Publicado: (2020)

Optimal immunosuppressor induces stable gut microbiota after liver transplantation
por: Jiang, Jian-Wen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_t3odi9hlm1k71sb4fje65o0952